舒肝解郁胶囊联合喹硫平治疗首发精神分裂症的疗效及对氧化应激水平的影响

Effect of Shugan Jieyu capsule combined with quetiapine on clinical efficacy and oxidative stress level of first-episode schizophrenia

目的观察舒肝解郁胶囊联合喹硫平治疗首发精神分裂症的疗效及对氧化应激水平的影响。方法选取2017年5月~2018年10月我院收治的确诊为首发精神分裂症患者80例为研究对象,按随机原则分为两组。对照组40例患者给予口服喹硫平治疗,观察组40例患者给予口服舒肝解郁胶囊联合喹硫平治疗,观察两组患者PANSS评分、临床疗效、氧化应激性水平及安全性等方面的差异。结果观察组治疗后第21天及第42天阳性症状、阴性症状、精神病理、PANSS总分均明显低于对照组(P <0.05);观察组痊愈、显著进步患者明显多于对照组,观察组总有效率为92.5%与对照组总有效率87.5%比较,差异无统计学意义(P> 0.05);治疗后,两组患者血清中T-SOD、GSH-Px含量均明显升高(P <0.05),而CAT及MDA含量显著降低(P <0.05),而观察组患者各指标增高或降低程度较对照组明显(P <0.05);观察期间两组不良反应症状发生率比较,差异均无统计学意义(P> 0.05)。结论舒肝解郁胶囊联合喹硫平可有效改善首发精神分裂症患者临床症状,安全性高,有助于患者氧化应激能力的提升。

Objective To observe the effect of Shugan Jieyu Capsule combined with quetiapine on clinical efficacy and oxidative stress level of first-episode schizophrenia. Methods 80 patients diagnosed with first-episode schizophrenia admitted to our hospital from May 2017 to October 2018 were enrolled in the study.They were divided into two groups according to the random principle.The control group(40 patients) was treated with quetiapine orally,and the observation group(40 patients) was given Shugan Jieyu capsule combined with quetiapine orally.The differences of PANSS score,clinical efficacy,oxidative stress level and safety between two groups were observed. Results The positive symptoms,negative symptoms,psychopathology and PANSS scores in observation group were significantly lower than control group on the 21 st and 42 nd after treatment(P < 0.05).Although the total effective rate of observation group(92.5%) was no significantly higher than control group(87.5%)(P > 0.05),the number of patients recovered and improved significantly in observation group was significantly higher than control group(P < 0.05).After treatment,the serum T-SOD and GSH-Px levels in both groups were significantly increased(P < 0.05),while the levels of CAT and MDA were significantly decreased(P < 0.05),while the indexes in observation group were significantly higher or lower than those in control group(P < 0.05).There was no significant difference in the incidence of adverse reactions between two groups during the observation period(P > 0.05). Conclusion Shugan Jieyu Capsule combined with quetiapine can effectively improve the clinical symptoms of first-episode schizophrenia,especially the negative symptoms.It has high safety and is helpful to enhance the oxidative stress ability of patients.